Literature DB >> 3742890

Dynamic heterogeneity: isolation of murine tumor cell populations enriched for metastatic variants and quantification of the unstable expression of the phenotype.

S D Young, R P Hill.   

Abstract

Recent studies have indicated that KHT fibrosarcoma or B16 melanoma cell variants capable of forming experimental metastases in the lungs of mice after i.v. injection are created stochastically at high rates (approximately 10(-5)/cell/generation). Expression of this phenotype is unstable and hence expanding populations of tumor cells establish a dynamic equilibrium between a small subpopulation of metastatic variants and a large compartment of nonmetastatic cells. In the present experiments, cell suspensions were prepared from the lungs of mice bearing 'experimental' metastases and the tumor cells contained in them were tested for their metastatic efficiency (ME) using the lung colony assay. The ME of the recovered tumor cell populations was found to be a function of the time of metastatic growth in the animal. Tumor cells isolated soon after the initial i.v. injection, i.e. derived from micrometastases, are highly metastatic while populations recovered from macroscopic nodules are similar to parental lines in their ability to colonize the lung. These results are consistent with the prediction of the above 'dynamic heterogeneity' model that nascent lung metastases should be composed largely of tumor cells expressing the variant metastatic phenotype, but that the proportion of such variants should decline during growth to the equilibrium (parental population) level. Mathematical analysis of the results indicates that the effective rate of reversion of the variant phenotype is approximately 10(-1)/cell/generation.

Entities:  

Mesh:

Year:  1986        PMID: 3742890     DOI: 10.1007/bf00117930

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  70 in total

Review 1.  Mechanisms of metastasis.

Authors:  E Roos; K P Dingemans
Journal:  Biochim Biophys Acta       Date:  1979-02-04

2.  Heterogeneity and variability of artificial lung colony-forming ability among clones from mouse fibrosarcoma.

Authors:  N Suzuki; H R Withers; M W Koehler
Journal:  Cancer Res       Date:  1978-10       Impact factor: 12.701

3.  Characterization of tumor lines derived from spontaneous metastases of a transplanted murine sarcoma.

Authors:  A Mantovani; R Giavazzi; G Alessandri; F Spreafico; S Garattini
Journal:  Eur J Cancer       Date:  1981-01       Impact factor: 9.162

4.  Radiation-induced changes in the in vivo growth rate of KHT sarcoma cells: implications for the comparison of growth delay and cell survival.

Authors:  R P Hill
Journal:  Radiat Res       Date:  1980-07       Impact factor: 2.841

5.  Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential.

Authors:  T Turpeenniemi-Hujanen; U P Thorgeirsson; I R Hart; S S Grant; L A Liotta
Journal:  J Natl Cancer Inst       Date:  1985-07       Impact factor: 13.506

6.  Factors influencing the quantitative estimation of the in vivo survival of cells from solid tumors.

Authors:  R F Kallman; G Silini; L M Van Putten
Journal:  J Natl Cancer Inst       Date:  1967-09       Impact factor: 13.506

7.  High-frequency generation of new immunoresistant tumor variants during metastasis of a cloned murine tumor line (ESb).

Authors:  K Bosslet; V Schirrmacher
Journal:  Int J Cancer       Date:  1982-02-15       Impact factor: 7.396

8.  Cancer metastasis is selective or random depending on the parent tumour population.

Authors:  J E Talmadge; I J Fidler
Journal:  Nature       Date:  1982-06-17       Impact factor: 49.962

9.  Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms.

Authors:  M A Cifone; I J Fidler
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

10.  Phenotypic drift of metastatic and cell-surface properties of mammary adenocarcinoma cell clones during growth in vitro.

Authors:  A Neri; G L Nicolson
Journal:  Int J Cancer       Date:  1981-12       Impact factor: 7.396

View more
  15 in total

1.  N-linked oligosaccharides and metastatic propensity in in vivo selected mouse mammary adenocarcinoma cells.

Authors:  P J Seberger; E M Scholar; L Kelsey; W G Chaney; J E Talmadge
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

2.  Modulation of clonal progression in B16F1 melanoma cells.

Authors:  J F Harris; A F Chambers; A S Tam
Journal:  Clin Exp Metastasis       Date:  1991 Mar-Apr       Impact factor: 5.150

3.  Dynamic heterogeneity: metastatic variants to liver are generated spontaneously in mouse embryonal carcinoma cells.

Authors:  J F Harris; M W Best
Journal:  Clin Exp Metastasis       Date:  1988 Nov-Dec       Impact factor: 5.150

4.  Dynamic heterogeneity: experimental metastasis studies with RIF-1 fibrosarcoma.

Authors:  B M Korycka; R P Hill
Journal:  Clin Exp Metastasis       Date:  1989 Jan-Feb       Impact factor: 5.150

5.  Clonal heterogeneity in plasminogen activator activity produced by two murine tumor cell lines.

Authors:  L H Brail; R P Hill
Journal:  Clin Exp Metastasis       Date:  1995-11       Impact factor: 5.150

Review 6.  Tumor progression: potential role of unstable genomic changes.

Authors:  R P Hill
Journal:  Cancer Metastasis Rev       Date:  1990-09       Impact factor: 9.264

7.  A fluorescent orthotopic model of metastatic cervical carcinoma.

Authors:  Rob A Cairns; Richard P Hill
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

8.  The effectiveness of cis-platinum, cyclophosphamide and melphalan in treating disseminated tumor cells in mice.

Authors:  A Kanclerz; J D Chapman
Journal:  Clin Exp Metastasis       Date:  1987-09       Impact factor: 5.150

9.  Use of NeoR B16F1 murine melanoma cells to assess clonality of experimental metastases in the immune-deficient chick embryo.

Authors:  A F Chambers; S Wilson
Journal:  Clin Exp Metastasis       Date:  1988 Mar-Apr       Impact factor: 5.150

10.  Drug sensitivity and metastatic ability in B16 melanoma cells.

Authors:  A Jang; R P Hill
Journal:  Clin Exp Metastasis       Date:  1991 Jul-Aug       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.